Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark A Socinski
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
484 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- Providence Hospital
Mobile, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Veteran'S Administration Medical Center
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- Feather River Cancer Center
Chico, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Long Beach Memorial Medical Center-Todd Cancer Institute
Long Beach, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente-Cadillac
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Memorial Medical Center
Modesto, California, United States
- El Camino Hospital
Mountain View, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Hematology and Oncology Associates-Oakland
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Tom K Lee Inc
Oakland, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Valley Care Health System - Pleasanton
Pleasanton, California, United States
- Valley Medical Oncology Consultants
Pleasanton, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- Kaiser Permanente-San Diego Mission
San Diego, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- Naval Medical Center -San Diego
San Diego, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Doctors Medical Center- Jc Robinson Regional Cancer Center
San Pablo, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jun 2008
- Primary completion
- 8 Nov 2013
- Completion
- 28 May 2015
- Last update posted
- 23 Jun 2026
- Registered enrollment
- 210
- Registry id
- NCT00693992
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.